Chih-Hsien Chang

Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy.

Gann Ting, Chih-Hsien Chang, Hsin‐Ell Wang · PubMed · 2009 · 84 citations

Pharmacy, Oncology, Pharmaceutics +17

Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model

Ya‐Jen Chang, Chih-Hsien Chang, Chia‐Yu Yu et al. · Nuclear Medicine and Biology · 2009 · 79 citations

Medicine, Oncology, Pharmacology +13

Biodistribution, pharmacokinetics and imaging of 188Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model

Liang‐Cheng Chen, Chih-Hsien Chang, Chia‐Yu Yu et al. · Nuclear Medicine and Biology · 2007 · 74 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Biodistribution, pharmacokinetics and PET Imaging of [18F]FMISO, [18F]FDG and [18F]FAc in a sarcoma- and inflammation-bearing mouse model

Ren-Shyan Liu, Ta-Kai Chou, Chih-Hsien Chang et al. · Nuclear Medicine and Biology · 2009 · 68 citations

Medicine, Nuclear Medicine, Radiology +13

Gene-editing by CRISPR–Cas9 in combination with anthracycline therapy <i>via</i> tumor microenvironment-switchable, EGFR-targeted, and nucleus-directed nanoparticles for head and neck cancer suppression

Chen-Shen Wang, Chih-Hsien Chang, Tsai‐Yu Tzeng et al. · Nanoscale Horizons · 2021 · 57 citations · Full text

Medicine, Biotechnology, Oncology +17